BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Bostwick Laboratories Files for $100M IPO


3/10/2008 7:07:07 AM

GLEN ALLEN, Va.--(BUSINESS WIRE)--Bostwick Laboratories, Inc. today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of its common stock. Bostwick Laboratories will offer all of the shares to be issued and sold in the initial public offering.

Banc of America Securities LLC and Wachovia Securities are acting as joint book-running managers for the offering. In addition, William Blair & Company, L.L.C. and Cowen and Company, LLC are acting as co-managers for the offering.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release is not an offer to sell nor is it a solicitation of an offer to buy any securities nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. Any offers, or solicitations to buy, will be made solely by means of a prospectus filed with the Securities and Exchange Commission.

Copies of the preliminary prospectus relating to this offering, when available, may be obtained from Banc of America Securities LLC, Capital Markets (Prospectus Fulfillment) by e-mail to dg.prospectus_distribution@bofasecurities.com or by mail to Banc of America Securities LLC, Capital Markets Operations, 100 West 33rd Street, 3rd Floor, New York, NY 10001, or from Wachovia Securities by e-mail to equity.syndicate@wachovia.com or by mail to Wachovia Securities, 375 Park Avenue, 4th floor, Attn: Equity Syndicate, New York, NY 10152.

About Bostwick Laboratories, Inc.

Bostwick Laboratories is a specialized anatomic pathology laboratory focused on the diagnosis of cancer. Bostwick Laboratories is a leader in urologic anatomic pathology, with expertise and a growing presence in the gynecology, gastroenterology, and nephrology sectors of the anatomic pathology market. Bostwick Laboratories is headquartered in Glen Allen, Virginia and operates five laboratories located in Virginia, Arizona, New York, Florida, and London, England.

Contact: Bostwick Laboratories, Inc. Gary Levine, 804-967-9225 x2200 (Chief Financial Officer) GLevine@bostwicklaboratories.com

Source: Bostwick Laboratories, Inc.

Read at Reuters
Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES